Böck, S., Jung, A., Laubender, R. P., Neumann, J., Egg, R., Goritschan, C., . . . Heinemann, V. (2013). EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: Translational results from the randomised, crossover phase 3 trial AIO-PK0104. British journal of cancer, 108(2), . https://doi.org/10.1038/bjc.2012.495
Chicago-Zitierstil (17. Ausg.)Böck, Stefan, et al. "EGFR Pathway Biomarkers in Erlotinib-treated Patients with Advanced Pancreatic Cancer: Translational Results from the Randomised, Crossover Phase 3 Trial AIO-PK0104." British Journal of Cancer 108, no. 2 (2013). https://doi.org/10.1038/bjc.2012.495.
MLA-Zitierstil (9. Ausg.)Böck, Stefan, et al. "EGFR Pathway Biomarkers in Erlotinib-treated Patients with Advanced Pancreatic Cancer: Translational Results from the Randomised, Crossover Phase 3 Trial AIO-PK0104." British Journal of Cancer, vol. 108, no. 2, 2013, https://doi.org/10.1038/bjc.2012.495.